Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD?

Gastrointestinal Endoscopy

Volumn 68, Issue 5, 2008, Pages 856-858

  Lagergren, Jesper ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EDITORIAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; EARLY DETECTION OF CANCER; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL REFLUX; HUMANS; RISK FACTORS;

EID: 54449087673     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2008.04.020     Document Type: Editorial

References (17)

1. Lagergren J., Bergström R., Lindgren A., et al. Symptomatic gastroesophageal reflux is a strong risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
2. Lagergren J., Ye W., Bergström R., et al. Utility of endoscopic screening for upper gastrointestinal adenocarcinoma. JAMA 284 (2000) 961-962
3. Berrino F., Gatta G., Chessa E., et al. Introduction: the EUROCARE II Study. Eur J Cancer 34 (1998) 2139-2153
4. Rubenstein J.H., Sonnenberg A., Davis J., et al. Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc 68 (2008) 849-855
5. Ronkainen J., Aro P., Storskrubb T., et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129 (2005) 1825-1831
6. Inadomi J.M., Sampliner R., Lagergren J., et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 138 (2003) 176-186
7. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97 (2002) 1888-1895
8. Mashimo H., Wagh M.S., and Goyal R.K. Surveillance and screening for Barrett esophagus and adenocarcinoma. J Clin Gastroenterol 39 (2005) 33-41
9. Thomas T., Abrams K.R., De Caestecker J.S., et al. Meta analysis: cancer risk in Barrett's oesophagus. Aliment Pharmacol Ther 26 (2007) 1465-1477
10. Lim C.H., Treanor D., Dixon M.F., et al. Low-grade dysplasia in Barrett's esophagus has a high risk of progression. Endoscopy 39 (2007) 581-587
11. Vakil N., van Zanten S.V., Kahrilas P., et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101 (2006) 1900-1920
12. Jamieson G.G., Mathew G., Ludemann R., et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 91 (2004) 943-947
13. Viklund P., Wengström Y., Rouvelas I., et al. Quality of life and persisting symptoms after esophageal cancer surgery. Eur J Cancer 42 (2006) 1407-1414
14. Rouvelas I., Zeng W., Lindblad M., et al. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol 6 (2005) 864-870
15. Picasso M., Blanchi S., Filiberti R., et al. Mucosectomy for high-grade dysplasia in Barrett's esophagus. Minim Invasive Ther Allied Technol 15 (2006) 325-330
16. Prasad G.A., Wang K.K., Buttar N.S., et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 132 (2007) 1226-1233
17. Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?. Gut 54 (2005) 1-5